Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
Researchers at the MTN include international investigators and community and industry partners who work together to evaluate promising microbicide products.
More than 25 clinical research sites on four continents have partnered with the Microbicide Trials Network in the conduct of its clinical trials.
The MTN partners with key civil society groups and other stakeholders to solicit their views on proposed studies and to discuss issues related to study implementation.
The Lima, Peru and Blantyre, Malawi sites for MTN-035 have activated.
DESIRE will be discussed at a workshop taking place at the upcoming Biomedical HIV Prevention Summit.
The Chiang Mai site for the MTN-035 rectal microbicide study has been activated.
The MTN will be holding its final in-country stakeholder meeting for MTN-042 and MTN-043 in Harare, Zimbabwe, January 28-29, 2020.
Presentations and photos from our MTN 2019 Regional Meeting have been posted along with a music video about REACH.
Results of open-label study of a vaginal ring for HIV prevention suggest women are interested in and willing to use it
What do people who practice anal sex desire for preventing HIV?
Microbicide Trials Network